MarketPeel
Insider Trading Intelligence
LW

Lai Wang

ONC
GLOBAL HEAD OF R&D · BEONE MEDICINES LTD. · CIK 0001852291
FILING MIX · LIFETIME28%/72%
BUYS
7
SELLS
18
TOTAL VALUE
$5.49M
COMPANIES
1
ACTIVE SINCE
Jun 2025
HOLDINGS NOW
0
AVG SELL PX
$297.55
TRADE KIND
SHOWING 25 / 25
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
13 backtested trades · 8 horizons · 19 pending
Forward-return performance of every backtestable P/S trade by Lai Wang, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d13+38.46%+0.85%+0.15%+0.70%+1.64%
14d13+84.62%-3.97%+0.94%-4.92%-6.88%
30d13+61.54%+0.73%+3.27%-2.54%-4.70%
60d13+7.69%+14.10%+5.13%+8.96%+14.28%
90d13+7.69%+15.54%+8.23%+7.30%+16.00%
180d13+7.69%+18.59%+11.36%+7.24%+7.72%
1y13(6 pending)+14.29%+5.27%+23.88%-18.61%-15.72%
2y13(13 pending)
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
ONC · 0 shares · as of Jun 23, 2026
0427,521855,0431,282,5641,710,0852026SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2025
2025
2025
2026
2026
FLOW · 7 buys / 18 sellsCOVERAGE · 5 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
ONC
BEONE MEDICINES LTD.
SALE
President, Global Head of R&D
1,068$276.74$295.6K0Jun 23, 2026Jun 25, 2026View →
ONC
BEONE MEDICINES LTD.
SALE
President, Global Head of R&D
1,169$265.39$310.2K0Jun 16, 2026Jun 18, 2026View →
ONC
BEONE MEDICINES LTD.
PURCHASEGRANT
Stock grant
229,775229,775Jun 11, 2026Jun 15, 2026View →
ONC
BEONE MEDICINES LTD.
SALE
President, Global Head of R&D
756$261.00$197.3K0Jun 11, 2026Jun 15, 2026View →
ONC
BEONE MEDICINES LTD.
PURCHASEGRANT
Stock grant
118,6251,710,085Jun 11, 2026Jun 15, 2026View →
ONC
BEONE MEDICINES LTD.
SALE
President, Global Head of R&D
40$270.73$10.8K0Jun 8, 2026Jun 10, 2026View →
ONC
BEONE MEDICINES LTD.
SALE
President, Global Head of R&D
1,327$269.34$357.4K40Jun 8, 2026Jun 10, 2026View →
ONC
BEONE MEDICINES LTD.
PURCHASEGRANT
Stock grant
55,0291,619,059Mar 6, 2026Mar 10, 2026View →
ONC
BEONE MEDICINES LTD.
PURCHASEGRANT
Stock grant
112,6061,564,030Mar 6, 2026Mar 10, 2026View →
ONC
BEONE MEDICINES LTD.
PURCHASEGRANT
Stock grant
427,8951,451,424Dec 31, 2025Jan 5, 2026View →
ONC
BEONE MEDICINES LTD.
SALE10b5-1
10b5-1 plan
5,000$350.06$1.75M0Sep 9, 2025Sep 11, 2025View →
ONC
BEONE MEDICINES LTD.
SALE10b5-1
10b5-1 plan
259$305.00$79.0K0Jul 30, 2025Jul 31, 2025View →
ONC
BEONE MEDICINES LTD.
SALE10b5-1
10b5-1 plan
292$302.92$88.5K1,059Jul 29, 2025Jul 31, 2025View →
ONC
BEONE MEDICINES LTD.
SALE10b5-1
10b5-1 plan
800$304.16$243.3K259Jul 29, 2025Jul 31, 2025View →
ONC
BEONE MEDICINES LTD.
SALE10b5-1
10b5-1 plan
2,949$302.00$890.6K1,351Jul 29, 2025Jul 31, 2025View →
ONC
BEONE MEDICINES LTD.
SALE10b5-1
10b5-1 plan
700$300.00$210.0K0Jul 18, 2025Jul 22, 2025View →
ONC
BEONE MEDICINES LTD.
SALE
Global Head of R&D
1,028$260.00$267.3K0Jun 23, 2025Jun 25, 2025View →
ONC
BEONE MEDICINES LTD.
SALE
Global Head of R&D
470$251.37$118.1K0Jun 17, 2025Jun 18, 2025View →
ONC
BEONE MEDICINES LTD.
SALE
Global Head of R&D
1,177$266.40$313.6K470Jun 16, 2025Jun 18, 2025View →
ONC
BEONE MEDICINES LTD.
PURCHASEGRANT
Stock grant
86,3591,058,304Jun 10, 2025Jun 12, 2025View →
ONC
BEONE MEDICINES LTD.
PURCHASEGRANT
Stock grant
162,565162,565Jun 10, 2025Jun 12, 2025View →
ONC
BEONE MEDICINES LTD.
SALE
Global Head of R&D
300$253.19$76.0K300Jun 6, 2025Jun 10, 2025View →
ONC
BEONE MEDICINES LTD.
SALE
Global Head of R&D
600$250.71$150.4K802Jun 6, 2025Jun 10, 2025View →
ONC
BEONE MEDICINES LTD.
SALE
Global Head of R&D
300$255.30$76.6K0Jun 6, 2025Jun 10, 2025View →
ONC
BEONE MEDICINES LTD.
SALE
Global Head of R&D
202$251.89$50.9K600Jun 6, 2025Jun 10, 2025View →
Other insiders · ONC
Loading peer insiders…
About this filer
CIK 0001852291
ROLE
Global Head of R&D
PRIMARY
ONC
COMPANIES
1
ACTIVE SINCE
Jun 2025
MARKETPEEL · /INSIDER/0001852291DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback